10x Genomics makes tools for studying individual cells.
10x Genomics, Inc. (TXG) is expected to report earnings on Thursday, November 5, 2026, after the close. Estimated release time 16:06 ET. Consensus EPS estimate is $-0.26.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-07 | Jun 2026 qtr | $-0.24 | $-0.14 | — | $151.04M |
| 2026-05-08 | Mar 2026 qtr | $-0.29 | $-0.10 | — | $150.84M |
| 2026-02-13 | Dec 2025 qtr | $-0.19 | $-0.13 | — | $166.03M |
| 2025-11-07 | Sep 2025 qtr | $-0.07 | $-0.22 | — | $149.00M |
| 2025-08-08 | Jun 2025 qtr | $-0.35 | $0.28 | — | $172.91M |
| 2025-05-09 | Mar 2025 qtr | $-0.45 | $-0.36 | — | $154.88M |
| 2025-02-13 | Dec 2024 qtr | $-0.29 | $-0.40 | — | $165.02M |
| 2024-10-29 | Sep 2024 qtr | $-0.34 | $-0.30 | +11.8% | $151.65M |
TXG has beaten consensus EPS in 1 of its last 1 scored quarters.
See TXG on the live calendar →